Opioid Labeling Changes Highlights AJPB Week in Review


Top articles of the week from The American Journal of Pharmacy Benefits.

5. Polygenetic Test Predicts Early Heart Disease Risk

An investigational test demonstrated superiority in detecting familial hypercholesterolemia compared with traditional methods. Read more.

4. Diabetes Drug Reverses Alzheimer's Disease in Mice

Mice treated with a repurposed diabetes medication performed better on learning and memory tests. Read more.

3. Plastic Surgery May Hold the Key to Reducing Migraine Pain

Migraine pain may be caused by nerves trapped between muscles, bones, and fascia, which could be reduced by forehead restoration surgery. Read more.

2. Medicaid Expansion Increased Access to Prenatal Care

Expanded Medicaid reduced the number of uninsured pregnant mothers by 8%. Read more.

1. FDA Revises Opioid Labeling to Restrict Pediatric Use

Cough and cold medicines containing codeine and hydrocodone are no longer indicated for use in pediatric patients. Read more.

Related Videos
A panel of 3 experts on multiple myeloma
A panel of 3 experts on multiple myeloma
Video 12 - "Collaborative Care: Key Stakeholders in HE Treatment and Recovery"
Video 11 - "Optimizing Transitions of Care for Hepatic Encephalopathy Patients"
Video 10 - "Valuable Metrics and Improving Adherence in Patients With ASCVD"
Video 9 - "The Role of Pharmacists in Treating Very High-Risk ASCVD"
Video 6 - "evaluating CDK4/6 inhibitor safety profiles"
Video 5 - "CDK4/6 Inhibitor Sequencing and NCCN Guidelines in mBC"
Video 8 - "Challenges of Concurrent Administration: RSV and Other Vaccines "
Video 7 - "Raising RSV Awareness Among High-Risk Patient Populations "
© 2024 MJH Life Sciences

All rights reserved.